Chargement en cours...
A vaccine strategy with multiple prostatic acid phosphatase-fused cytokines for prostate cancer treatment
Immunotherapy is one of the attractive treatment strategies for advanced prostate cancer. The US Food and Drug Administration (FDA) previously approved the therapeutic vaccine, sipuleucel-T, which is composed of autologous antigen-presenting cells cultured with a fusion protein [prostatic acid phosp...
Enregistré dans:
| Publié dans: | Oncol Rep |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4358080/ https://ncbi.nlm.nih.gov/pubmed/25632844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2015.3770 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|